1. Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study. (1st January 2021) Authors: Zhang, Wencheng; Yan, Cihui; Zhang, Tian; Chen, Xi; Dong, Jie; Zhao, Jingjing; Han, Dong; Wang, Jun; Zhao, Gang; Cao, Fuliang; Zhou, Dejun; Jiang, Hongjing; Tang, Peng; Zhao, Lujun; Yuan, Zhiyong; Wang, Quanren; Wang, Ping; Pang, Qingsong Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dysregulated Th1 cells in lung squamous cell carcinoma. Issue 6 (10th June 2022) Authors: Wang, Jiahui; Zhou, Jian; Zhou, Qiuru; Qi, Ying; Zhang, Peng; Yan, Cihui; Ren, Xiubao Journal: Journal of leukocyte biology Issue: Volume 112:Issue 6(2022) Page Start: 1567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Programmed death‐ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor. Issue 4 (25th April 2017) Authors: Zhang, Wencheng; Pang, Qingsong; Zhang, Xiaodong; Yan, Cihui; Wang, Qifeng; Yang, Jinsong; Yu, Shufei; Liu, Xiao; Pan, Yi; Yuan, Zhiyong; Wang, Ping; Xiao, Zefen Journal: Cancer science Issue: Volume 108:Issue 4(2017) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Radiotherapy plus camrelizumab affects peripheral CD8 T-cell differentiation subsets expressing PD-1, TIGIT, and CTLA-4 in esophageal squamous cell carcinoma. Issue 1 (10th January 2023) Authors: Guo, Zhoubo; Zhang, Kunning; Wei, Xiaoying; Li, Yanqi; Ma, Xiaoxue; Li, Yang; Han, Dong; Du, Qingwu; Zhang, Tian; Chen, Xi; Wei, Hui; Yan, Cihui; Zhang, Wencheng; Pang, Qingsong; Wang, Ping Journal: Journal of leukocyte biology Issue: Volume 113:Issue 1(2023) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma. (5th June 2021) Authors: Zhang, Wencheng; Yan, Cihui; Gao, Xuan; Li, Xiaoxia; Cao, Fuliang; Zhao, Gang; Zhao, Jingjing; Er, Puchun; Zhang, Tian; Chen, Xi; Wang, Yuwen; Jiang, Yao; Wang, Quanren; Zhang, Baozhong; Qian, Dong; Wang, Jun; Zhou, Dejun; Ren, Xiubao; Yu, Zhentao; Zhao, Lujun Journal: Oncologist Issue: Volume 26:Number 7(2021) Page Start: e1110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade. (31st December 2022) Authors: Yan, Cihui; Ma, Xiaoxue; Guo, Zhoubo; Wei, Xiaoying; Han, Dong; Zhang, Tian; Chen, Xi; Cao, Fuliang; Dong, Jie; Zhao, Gang; Gao, Xuan; Wang, Tao; Jiang, Yao; Wang, Ping; Pang, Qingsong; Zhang, Wencheng Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗